Stay updated on Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.

Latest updates to the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision indicator changed from v3.5.0 to v3.5.2. No user-facing content or functionality was altered.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedPublications section updated: added a new Leuk Lymphoma article on the AMN006 trial (NCT03695744) and removed an earlier Leuk Lymphoma citation; publication references were revised.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.3 has replaced the previous v3.4.2 label on the page.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded: Revision: v3.4.2. Removed: Revision: v3.4.1 and the government funding notice. These are administrative updates that do not modify trial data or eligibility requirements.SummaryDifference0.4%

- Check79 days agoChange DetectedAdded a government funding status notice with links to cc.nih.gov and opm.gov. Updated the site to revision v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check86 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; removed the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to Daratumumab with Bortezomib/Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.